arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up

Dare Bioscience, Inc.

DARE Health Care Biotechnology: Pharmaceutical Preparations
$0.65
▼ -5.4% Today
as of Oct 22, 16:48 ET
Last 30 days -11.41% Sep 14 → Oct 22
$0.64 $0.69 $0.75 $0.81 $0.87 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$0.69
High
$0.69
Low
$0.62
Volume
$327,900
Avg Vol
$355,209
Mkt Cap
$17M
P/E (TTM)
—
Beta
—
52w High
$3.78
52w Low
$0.62
Div Yield
—
Shares Out
$15M

Recent Press Releases & News last 60 days · 2 items

DARE earnings at a glance

Over its last 2 reports the stock rose the next day 2 times and fell 0, moving ±0.5% on average; after the most recent report on May 14, 2026 it moved +0.7%. DARE beat the consensus EPS estimate in 4 of its last 4 reported quarters. The share price of $0.65 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$0.62
$3.78
1% of range
Avg surprise (last 4)
+23.3%
Avg reaction (last 2)
+0.5%
100% positive

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.22$-0.53$0.15$0.84$1.52 Actual $-0.09Actual $-1.22Actual $-1.09Actual $-0.81Actual $1.52Actual $-0.55Actual $-0.50Est $-0.63Actual $-0.45Est $-0.55Actual $-0.28Est $-0.33Actual $-0.20Est $-0.33Actual $-0.20 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-5M$-3M$-2M$-1M$196,923 Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.20 — — — — financials
Thu May 14, 2026Mar/2026 $-0.20 $-0.33 +39.4% +60.0% +0.7% earnings
Thu Nov 13, 2025Sep/2025 $-0.28 $-0.33 +15.2% — — earnings
Thu Aug 14, 2025Jun/2025 $-0.45 $-0.55 +18.2% — — earnings
Tue May 13, 2025Mar/2025 $-0.50 $-0.63 +20.6% — +0.3% earnings
Mon Sep 30, 2024Sep 2024 $-0.55 — — — — financials
Sun Jun 30, 2024Jun 2024 $1.52 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.81 — — — — financials
Sat Sep 30, 2023Sep 2023 $-1.09 — — — — financials
Fri Jun 30, 2023Jun 2023 $-1.22 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.09 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$187,546$152,455—$2,262—$25,427—$41,691
Cost of revenue$319,889$242,325——$0$0——
Gross profit————————
Operating income$-3M$-3M—$-4M$-4M$-5M—$-5M
Net income$-3M$-3M—$-4M$-4M$-4M—$-5M
EPS (diluted)$-0.20$-0.21—$-0.28$-0.45$-0.50—$-0.55

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$13M$19M$25M$23M$5M$10M$16M$11M
Inventory————————
Total current assets$17M$22M$27M$25M$7M$12M$18M$15M
Total assets$22M$28M$32M$31M$13M$19M$22M$18M
Long-term debt————————
Total liabilities$23M$27M$30M$28M$26M$28M$28M$20M
Total equity$-560,100$734,451$3M$3M$-13M$-10M$-6M$-1M

Implied volatility — last 90 days

No IV snapshots yet for DARE.

IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.

Sector peers

DARE earnings FAQ

How does DARE stock usually react to earnings?

Across the last 2 reports the average next-day move was ±0.5%, up 2 times and down 0 times.

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.